Back to results
US 12,364,750 B1Granted
Conserved region T cell vaccines for coronavirus and methods of use
AssigneesTriad National Security, LLC, Oxford University Innovation Limited, The Trustees of the University of Pennsylvania, Beth Israel Deaconess Medical Center, Inc.
InventorsBette T. M. Korber, James Theiler, Dan Barouch, Drew Weissman, Tomas Hanke
Life of this patent
Estimating the term…
Abstract
Immunogenic compositions and methods of their use in eliciting immune responses to coronaviruses, such as SARS-CoV-2 are provided.
Claims20
An immunogenic composition comprising:
- one or more polypeptides with at least 99% sequence identity to any one of SEQ ID NOs:
- 11-14;
- or a nucleic acid encoding a polypeptide with at least 99% sequence identity to any one of SEQ ID NOs:
- 11-14;
- and
- a pharmaceutically acceptable carrier.
3 more elements
A vector comprising a nucleic acid encoding a polypeptide with at least 99% sequence identity to any one of SEQ ID NOs:
- 11-14.
Dependencies are inferred from the claim text.